hypothesis glutathione persister cells Drug-tolerant cancer are vulnerable to GPX4 inhibition FSP1 and histone deacetylases suppress
FSP1 and histone deacetylases suppress cancer persister cell ferroptosis Science Advances Tolerant Persister Cancer Cells and the Path to Resistance to Targeted Therapy Frontiers Cysteine Depletion, a Key Action to Challenge Cancer Cells to Ferroptotic Cell Death JCI CD8+ T cells sustain antitumor response by mediating crosstalk between adenosine A2A receptor and glutathione GPX4 Targeted therapy for drug tolerant persister cells after imatinib treatment for gastrointestinal stromal tumours British Journal of Cancer
Pay in 4 interest-free payments of $6.88 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Oct 12 - Oct 17




